insights_auto
Hvorfor har GMAB gått ned? 2,42%?
Gå mer i dybdenchevron_right
GMAB:CPH
Genmab
2 257,00 DKK
arrow_downward
−2,42%(−56,00) 1 D
2. okt., 17:00:00 GMT+2 · DKK
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for GMAB …
Åpne
2 274,00 DKK
Høy
2 314,00 DKK
Lav
2 235,00 DKK
Markedsverdi
140,71 mrd.
Snittvolum
112,20k
Volum
0,00
52 u høy
2 369,00 DKK
52 u lav
1 512,00 DKK
Utestående aksjer
62,41 mill.
Antall ansatte
3k
Åpne
2 274,00 DKK
Høy
2 314,00 DKK
Lav
2 235,00 DKK
Markedsverdi
140,71 mrd.
Snittvolum
112,20k
Volum
0,00
52 u høy
2 369,00 DKK
52 u lav
1 512,00 DKK
Utestående aksjer
62,41 mill.
Antall ansatte
3k
Nyhetssaker
Fra nettkilder og nyhetspartnere
Investing.com UK
·
for 19 timer siden
Genmab reports trial results for ovarian cancer drug candidate By Investing.com
TipRanks
·
for 1 døgn siden
Genmab Discloses Darwin Global as 5.11% Major Shareholder
Profil
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
Om Genmab
Administrerende direktørJan G. J. van de Winkel
Ansatte3,12k
Grunnlagt11. juni 1998
Hovedkontor-
Sektor-
Nettstedgenmab.com